menu
    • menu

    Company profile for Kairos Pharma

    NEW Drugs in Dev.: 3
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kairos Pharma is a clinical stage biopharmaceutical company that harnesses immunity against cancer and drug resistance. By doing so, we seek to transform the way cancer is treated by positively impacting patient outcomes while maintaining quality of life. Uniquely positioned to advance our novel drug development pipeline of peptide and small molecule cancer immunotherapeutics: KROS-101, 102, 201, 301, and 401 as well as thera...
    Kairos Pharma is a clinical stage biopharmaceutical company that harnesses immunity against cancer and drug resistance. By doing so, we seek to transform the way cancer is treated by positively impacting patient outcomes while maintaining quality of life. Uniquely positioned to advance our novel drug development pipeline of peptide and small molecule cancer immunotherapeutics: KROS-101, 102, 201, 301, and 401 as well as therapeutic agents ENV105 and ENV205 for drug resistance.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kairos PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2355 Westwood Blvd. #139 Los Angeles, CA 90064
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kairospharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kairospharmaltd/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/KairosPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kairos Pharma Wins 2025 R&D Award for Advanced Prostate Cancer
    Kairos Pharma Wins 2025 R&D Award for Advanced Prostate Cancer

    17 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251217192511/en/Kairos-Pharma-Wins-2025-Clinical-Trials-Arena-Research-and-Development-Excellence-Award-for-Advanced-Prostate-Cancer

    BUSINESSWIRE
    17 Dec 2025
    Share Share
    Kairos Pharma Provides Shareholder Update
    Kairos Pharma Provides Shareholder Update

    04 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251104131751/en/Kairos-Pharma-Provides-Shareholder-Update

    BUSINESS WIRE
    04 Nov 2025
    Share Share
    Kairos Presents on Ph 2 of ENV-105 in Advanced Prostate Cancer
    Kairos Presents on Ph 2 of ENV-105 in Advanced Prostate Cancer

    20 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251020246445/en/Kairos-Pharma-Presents-on-Phase-2-Trial-of-ENV-105-in-Advanced-Prostate-Cancer-at-European-Society-Medical-Oncologists-ESMO-Meeting

    BUSINESSWIRE
    20 Oct 2025
    Share Share
    Kairos Pharma To Unveil Phase 2 Prostate Cancer Trial Results
    Kairos Pharma To Unveil Phase 2 Prostate Cancer Trial Results

    07 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251007913966/en/Kairos-Pharma-to-Present-Positive-Safety-and-Efficacy-Data-from-Phase-2-Prostate-Cancer-Trial-at-ESMO-2025

    BUSINESSWIRE
    07 Oct 2025
    Share Share
    Kairos Pharma Ph 2 ENV105 Trial Shows Efficacy in Prostate Cancer
    Kairos Pharma Ph 2 ENV105 Trial Shows Efficacy in Prostate Cancer

    18 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250918393009/en/Kairos-Pharma-Announces-Positive-Interim-Efficacy-Analysis-of-Phase-2-Trial-of-ENV105-in-Advanced-Prostate-Cancer-with-Median-Progression-Free-Survival-of-Over-One-Year

    BUSINESSWIRE
    18 Sep 2025
    Share Share
    Kairos Pharma's KOL Event on ENV105 Efficacy in Prostate Cancer
    Kairos Pharma's KOL Event on ENV105 Efficacy in Prostate Cancer

    11 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250911712367/en/Kairos-Pharma-Announces-Virtual-KOL-Event-to-Provide-Perspectives-on-ENV105-Interim-Efficacy-Results-in-Advanced-Prostate-Cancer

    BUSINESSWIRE
    11 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search